Seeking Alpha

More on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the...

More on Monster Beverage (MNST) (previous): Goldman Sachs calls the response from the FDA on the energy drink health concerns relatively "benign" and encouraging for shareholders of the company. The common sense approach by consumers is likely to be moderation and increased oversight by parents - instead of anything resembling a ban or graphic warning labels. MNST +12.5% to $51.50.
Comments (2)
  • jean5566
    , contributor
    Comments (71) | Send Message
     
    now on play for coke or pepsi offer .
    27 Nov 2012, 01:33 PM Reply Like
  • Joseph Poma
    , contributor
    Comments (437) | Send Message
     
    Been saying this all along...

     

    http://seekingalpha.co...
    27 Nov 2012, 02:46 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|